Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial30

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial18

Views

Views
November 20240
December 20240
January 20251
February 20251
March 202515
April 20251
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Spain1
United Kingdom1
United States1
 

Top cities views

Views